|
|
|
|
|
|
|
|
|
|
J. Tate Thigpen, MD, discusses important findings in ovarian cancer, including findings from the CALYPSO trial, outcomes of a study evaluating delayed or early treatment of patients with rising CA-125, and findings from a phase III trial of gemcitabine plus cisplatin and radiation in cervical cancer patients. (7 minutes)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.